See also this year's filing and all EDGAR filings for this company.
PDF Report 0001560241_2022_G1_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001560241, G1 Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 243,565,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,013,000 |
| 3 | remainder_Assets | 8,516,000 |
| 4 | LiabilitiesCurrent | 27,613,000 |
| 5 | LiabilitiesNoncurrent | 6,750,000 |
| 6 | remainder_Liabilities | 76,190,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 231,632,164 |
| 9 | ResearchAndDevelopmentExpense | 77,122,271 |
| 10 | remainder_Expenses | 10,569,296 |
| 11 | remainder_Revenues | 34,711,374 |
| 12 | remainder_NetIncome | -6,066,288 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 254,094,000 |
| 1 | Liabilities | 110,553,000 |
| 2 | Expenses | 319,323,731 |
| 3 | Revenues | 34,711,374 |
| 4 | StockholdersEquity | 143,541,000 |
| 5 | NetIncome | -290,678,645 |
| 6 | ComprehensiveNetIncome | -290,678,645 |
| 7 | BaseVar | 362,374,196 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.122 |
| 9 | EconomicCapitalRatio | 1.53 |
Edgar->Model Mapping
Feature Distribution
Change over Time
